BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12423009)

  • 1. Choice of an ELISA assay for screening postmortem blood for amphetamine and/or methamphetamine.
    Kupiec T; DeCicco L; Spiehler V; Sneed G; Kemp P
    J Anal Toxicol; 2002 Oct; 26(7):513-8. PubMed ID: 12423009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a microtiter plate ELISA for screening of postmortem blood for opiates and benzodiazepines.
    Kemp P; Sneed G; Kupiec T; Spiehler V
    J Anal Toxicol; 2002 Oct; 26(7):504-12. PubMed ID: 12423008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of a microtiter plate ELISA for screening of postmortem blood for cocaine and metabolites.
    Spiehler V; Isenschmid DS; Matthews P; Kemp P; Kupiec T
    J Anal Toxicol; 2003; 27(8):587-91. PubMed ID: 14670138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
    Laloup M; Tilman G; Maes V; De Boeck G; Wallemacq P; Ramaekers J; Samyn N
    Forensic Sci Int; 2005 Oct; 153(1):29-37. PubMed ID: 15922530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antemortem and postmortem methamphetamine blood concentrations: three case reports.
    McIntyre IM; Nelson CL; Schaber B; Hamm CE
    J Anal Toxicol; 2013; 37(6):386-9. PubMed ID: 23719317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix effect and cross-reactivity of select amphetamine-type substances, designer analogues, and putrefactive amines using the Bio-Quant direct ELISA presumptive assays for amphetamine and methamphetamine.
    Apollonio LG; Whittall IR; Pianca DJ; Kyd JM; Maher WA
    J Anal Toxicol; 2007 May; 31(4):208-13. PubMed ID: 17555644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening postmortem whole blood for oxycodone by ELISA response ratios.
    Spiehler VR; DeCicco L; McCutcheon JR; Kupiec T; Kemp P
    J Forensic Sci; 2004 May; 49(3):621-6. PubMed ID: 15171187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening postmortem blood and tissues for nine classes [correction of cases] of drugs of abuse using automated microplate immunoassay.
    Moore KA; Werner C; Zannelli RM; Levine B; Smith ML
    Forensic Sci Int; 1999 Dec; 106(2):93-102. PubMed ID: 10664895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the sensitivity and specificity of six immunoassays for the detection of amphetamines in urine.
    Verstraete AG; Heyden FV
    J Anal Toxicol; 2005; 29(5):359-64. PubMed ID: 16105261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELISA Detection of 30 New Amphetamine Designer Drugs in Whole Blood, Urine and Oral Fluid using NeogenĀ® "Amphetamine" and "Methamphetamine/MDMA" Kits.
    Nieddu M; Burrai L; Baralla E; Pasciu V; Varoni MV; Briguglio I; Demontis MP; Boatto G
    J Anal Toxicol; 2016 Sep; 40(7):492-7. PubMed ID: 27405364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of an ELISA method for screening methadone in postmortem blood.
    Juhascik M; Habbel S; Barron W; Behonick G
    J Anal Toxicol; 2006 Oct; 30(8):617-20. PubMed ID: 17132262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Cozart microplate ELISA and GC-MS detection of methadone and metabolites in human hair.
    Cooper G; Wilson L; Reid C; Baldwin D; Hand C; Spiehler V
    J Anal Toxicol; 2005 Oct; 29(7):678-81. PubMed ID: 16419400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of methamphetamine in sweat by EIA and GC-MS.
    Fay J; Fogerson R; Schoendorfer D; Niedbala RS; Spiehler V
    J Anal Toxicol; 1996 Oct; 20(6):398-403. PubMed ID: 8889675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of amphetamine/methamphetamine and other cross-immunoreactive sympathomimetic amines in urine samples by serial dilution testing.
    Woodworth A; Saunders AN; Koenig JW; Moyer TP; Turk J; Dietzen DJ
    Clin Chem; 2006 Apr; 52(4):743-6. PubMed ID: 16455869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex assay of amphetamine, methamphetamine, and ecstasy drug using CEDIA technology.
    Loor R; Lingenfelter C; Wason PP; Tang K; Davoudzadeh D
    J Anal Toxicol; 2002; 26(5):267-73. PubMed ID: 12166813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscreen ONLINE amphetamine, and a modified Abuscreen ONLINE amphetamine screening immunoassays for the detection of amphetamine (AMP), methamphetamine (MTH), 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA) in human urine.
    Stout PR; Klette KL; Wiegand R
    J Anal Toxicol; 2003; 27(5):265-9. PubMed ID: 12908938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood.
    Gjerde H; Langel K; Favretto D; Verstraete AG
    Forensic Sci Int; 2015 Nov; 256():42-5. PubMed ID: 26295911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine, 3,4-methylenedioxymethamphetamine, and 3,4-methylenedioxyethylamphetamine in urine by fast gas chromatography-mass spectrometry.
    Klette KL; Jamerson MH; Morris-Kukoski CL; Kettle AR; Snyder JJ
    J Anal Toxicol; 2005 Oct; 29(7):669-74. PubMed ID: 16419398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine in antemortem blood and urine by radioimmunoassay and GC/MS.
    Rasmussen S; Cole R; Spiehler V
    J Anal Toxicol; 1989; 13(5):263-7. PubMed ID: 2615336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphetamines in hair by enzyme-linked immunosorbent assay.
    Sweeney SA; Kelly RC; Bourland JA; Johnson T; Brown WC; Lee H; Lewis E
    J Anal Toxicol; 1998 Oct; 22(6):418-24. PubMed ID: 9788515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.